Clinical Trials in Arizona

Showing 1881-1900 of 8,032 trials

EXOMIND (BTL-699-2) for Improvement of Mental Well-being

NCT06899646

The goal of this clinical trial is to evaluate if the treatment with EXOMIND (BTL-699-2) device is able to improve mental well-being in adults above the age of 22 years. The main question it aims to answer is: Does the treatment with EXOMIND (BTL-699-2) device improve mental well-being? Participants will be asked to: * Undergo four treatments * Complete the Warwick Edinburgh Mental Well-being Scale * Complete the Therapy Comfort Questionnaire * Complete the Subject Satisfaction \& Mental Wellness Questionnaire

Well-Being, Psychological

BTL Industries Ltd.38 participantsStarted Jul 2024

Gilbert, Arizona, United States • Winter Garden, Florida, United States • New York, New York, United States

COMPLETEDPhase 335 miles

A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

NCT02908672

This is a Phase III, double-blinded, placebo-controlled, randomized, multicenter study designed to evaluate the efficacy, safety, and pharmacokinetics of atezolizumab + cobimetinib + vemurafenib compared with placebo + cobimetinib + vemurafenib in patients with previously untreated BRAFv600 mutation-positive metastatic or unresectable locally advanced melanoma.

Melanoma

Hoffmann-La Roche514 participantsStarted Jan 2017

Birmingham, Alabama, United States • Tempe, Arizona, United States • Springdale, Arkansas, United States +107 more locations

EXOMIND (BTL-699-2) for Improvement of Mental Well-being

A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

Find Trials by Condition in Arizona

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)

Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)

Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)

Wavefront-guided LASIK for Monovision Treatment of Myopic Subjects With Presbyopia

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress

A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products

SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

Non-surgical Spinal Decompression Therapy and Outcomes